drugset / Trial / NCT02903823

Intrathecal (IT) Baclofen Drug Distribution

NCT02903823

Phase 4 Completed 27 enrolled Vanderbilt University Medtronic · collab
NaSingle-groupOpen-labelBasic science

Summary

The goal of this pilot study to determine whether there is a significant therapeutic advantage to place the ITB catheter within the cervical, thoracic or lumbar region of the spine. It is also a goal of this pilot study to determine whether the origin of spasticity influences the effect of Lioresal Intrathecal (baclofen injection) on ITB catheters located in the cervical, thoracic or lumbar regions of the spine. The investigators propose to study the impact of catheter location on the reduction in spasticity within a group of patients who are scheduled for ITB trial.

Timeline

Start
2016-04-22
Primary completion
2019-02-01
Completion
2019-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 50 ug Intrathecal

Indications

No indication recorded.